Trexo Robotics

trexorobotics.com →

-61%

est. 2Y upside i

Healthcare

Exoskeletons to help people walk, starting with children

Rank

#595

Sector

Medical Devices

Est. Liquidity

~4Y

Data Quality

Data: Medium

Trexo Robotics presents a moderate upside opportunity driven by its specialized product in an underserved market and strong user traction.

Last updated: February 23, 2026

Bull (30%)+300%

Trexo achieves significant market penetration in its niche, secures favorable insurance coverage, and is acquired by a major medical device company at a premium valuation.

Base (40%)+100%

Trexo continues steady growth, expands internationally, and secures further funding rounds, leading to a moderate valuation increase or acquisition.

Bear (30%)-70%

Market adoption is slower than expected, insurance coverage remains a challenge, or larger competitors enter the pediatric exoskeleton market, leading to a down round or low-value exit.

Est. time to liquidity~4.0 years

Preference Stack Risk

low

Based on an estimated current valuation of $35M and total funding of $1.54M, investors hold approximately $1.54M in liquidation preferences, which is a low percentage of the valuation.

Dilution Risk

high

With only $1.54M raised to date and high capital intensity, Trexo Robotics will require substantial additional funding rounds (Series A, B, etc.), leading to significant future dilution for common shareholders.

Secondary Liquidity

none

As an early-stage, privately held company, there is currently no active secondary market for Trexo Robotics' equity.

Community

Valuation Sentiment

Our model estimates -61% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.